Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05053100 · ClinicalTrials.gov registry record
Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 100
- Enrollment target
NCT05053100: Completed study, sponsored by Mayo Clinic.
NCT05053100 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05053100 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
This study evaluates the risks and experience of blood clots and bleeding in patients with blood cancers. While it is standard of care to use medications to reduce the risk of blood clots in hospitalized individuals, some patients with blood cancers have low platelet counts that can increase the concern for bleeding complications associated with these medications. At this time, the optimal management strategies for blood clots are not well known for patients with blood cancers. This pilot study evaluates additional information that could help doctors know which patients are at highest risk for blood clots.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Electronic Health Record Review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-08-17 |
| Est. Completion | 2024-07-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05053100
The ClinicalTrials.gov registry entry for NCT05053100 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biospecimen Collection is the first listed.
NCT05053100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05053100 about?
NCT05053100 is a clinical study titled "Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT Study". This study evaluates the risks and experience of blood clots and bleeding in patients with blood cancers. While it is standard of care to use medications to reduce the risk of blood clots in hospitalized individuals, some patients with blood cancers have low platelet counts that can increase the con...
What is the current status of trial NCT05053100?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2021-08-17. Estimated completion is 2024-07-05.
What interventions are being tested in trial NCT05053100?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Electronic Health Record Review (OTHER).
Who is sponsoring clinical trial NCT05053100?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.